Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

被引:2
作者
Jiang, Jie [1 ]
Liu, Bin [2 ]
Liu, Ruilin [3 ]
Yang, Wenzhuo [1 ]
机构
[1] Tongji Univ, Shanghai Tongji Hosp, Dept Gastroenterol & Hepatol, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China
[2] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China
[3] Tongji Univ, Shanghai Tongji Hosp, Dept Pulm, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2021年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; TASP1; prognosis; biological functional networks; CANCER-CELL PROLIFERATION; GENE-EXPRESSION; WEB SERVER; TUMOR; BREAST; NETWORKS; INVASION; PROTEASE; PROTEOLYSIS; ENVIRONMENT;
D O I
10.2147/CMAR.S296069
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Taspase 1 (TASP1) is a highly conserved protease involved in site-specific proteolysis. Existing researches have revealed a link between TASP1 expression and carcinogenesis. However, limited data are available regarding the prognosis and functions of TASP1 in hepatocellular carcinoma (HCC). Methods: Western Blotting and qRT-PCR were employed to evaluate the level of TASP1 in HCC cell lines and clinical specimens. TASP1 expression was further calculated in clinical specimens by immunohistochemistry and the mRNA level of TASP1 in HCC was analyzed using Oncomine and UALCAN databases. The TASP1 promoter methylation modification was shown via MEXPRESS and UALCAN. The association between TASP1 expression and postoperative prognosis was evaluated using Kaplan-Meier and Cox regression analysis in clinical patients. The effect of TASP1 on HCC prognosis was analyzed via Kaplan-Meier plotter, GEPIA and UALCAN. Additionally, the regulators, kinases, miRNA and transcription factor targets of TASP1 were identified using LinkedOmics. Moreover, cBioPortal was used to detect the genetic alteration of TASP1. Finally, TIMER was utilized to assess the relation between TASP1 and the immune cell infiltration, whereas the correlation of TASP1 with three immune factors was detected through TISIDB. Results: TASP1 expression was increased in HCC cell lines and HCC tissues. CNV and DNA methylation of TASP1 were changed. Survival analysis revealed that high TASP1 expression was correlated with overall survival (OS). Functional network analysis about TASP1 in HCC showed that the double-strand break repair, peptidyl-threonine modification, spindle organization, peptidyl-lysine modification and microtubule-based movement were modulated. Furthermore, TASP1 expression revealed puissant relation to the infiltration of immune cells and three immune factors in HCC. Conclusion: These data indicate that TASP1 may act as a potential prognostic marker in HCC and regulate HCC via multiple mechanisms.
引用
收藏
页码:2517 / 2537
页数:21
相关论文
共 50 条
[11]   Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma [J].
Zhang, Yaojun ;
Xi, Shaoyan ;
Chen, Jinbin ;
Zhou, Dongsheng ;
Gao, Hengjun ;
Zhou, Zhongguo ;
Xu, Li ;
Chen, Minshan .
JOURNAL OF CANCER, 2017, 8 (15) :2992-3000
[12]   GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma [J].
Wang, Guifu ;
Bai, Xuesong ;
Jiang, Guoqing ;
Jin, Shengjie ;
Wang, Qian ;
Wang, Aoqing ;
Peng, Rui ;
Ke, Aiwu ;
Bai, Dousheng .
BIOENGINEERED, 2021, 12 (01) :30-43
[13]   Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma [J].
Zha, Tian-Zhou ;
Hu, Ben-Shun ;
Yu, Hai-Feng ;
Tan, Yong-Fei ;
Zhang, Yun ;
Zhang, Kai .
TUMOR BIOLOGY, 2012, 33 (06) :2125-2134
[14]   Overexpression of PSF1 is correlated with poor prognosis in hepatocellular carcinoma patients [J].
Zhou, Lei ;
Sun, Xue-jun ;
Liu, Chang ;
Wu, Qi-fei ;
Tai, Ming-hui ;
Wei, Ji-chao ;
Lei, Lei ;
Meng, Fan-di ;
Qu, Kai ;
Xu, Jia .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (01) :E56-E64
[15]   EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients [J].
Dai, Yaoyao ;
Tang, Zuxiong ;
Yang, Zongguo ;
Zhang, Lan ;
Deng, Qing ;
Zhang, Xiaofeng ;
Yu, Yongchun ;
Liu, Xing ;
Zhu, Junfeng .
CELL CYCLE, 2018, 17 (19-20) :2386-2397
[16]   Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients [J].
Zhao, Ze-Kun ;
Yu, Hai-Feng ;
Wang, Dao-Rong ;
Dong, Ping ;
Chen, Lei ;
Wu, Wen-Guang ;
Ding, Wen-Jun ;
Liu, Ying-Bin .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (45) :6651-6656
[17]   Overexpression of MMSET is Correlation with Poor Prognosis in Hepatocellular Carcinoma [J].
Zhou, Peng ;
Wu, Lie-Lin ;
Wu, Ke-Min ;
Jiang, Wei ;
Li, Jin-dong ;
Zhou, Le-du ;
Li, Xin-Ying ;
Chang, Shi ;
Huang, Yun ;
Tan, Hui ;
Zhang, Ge-Wen ;
He, Feng ;
Wang, Zhi-Ming .
PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (02) :303-309
[18]   Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma [J].
Zhang, Long-Hui ;
Wang, Dong ;
Li, Zhao ;
Wang, Gang ;
Chen, Ding-Bao ;
Cheng, Qian ;
Hu, Shi-Hua ;
Zhu, Ji-Ye .
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (04) :337-344
[19]   Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma [J].
Zheng, J. ;
Guo, X. ;
Gao, X. ;
Liu, H. ;
Tu, Y. ;
Zhang, Y. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (01) :57-63